Drug Type Fusion protein |
Synonyms second generation therapeutics (NeuroPhage Pharmaceuticals), NPT-133, NPT-289 |
Target |
Action inhibitors |
Mechanism APP inhibitors(Beta amyloid A4 protein inhibitors), α-synuclein inhibitors(Synuclein alpha inhibitors), Peptide aggregation inhibitors |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyloidosis | Discovery | United States | - | |
Neurodegenerative Diseases | Discovery | United States | - |